Design and evaluation of doxorubicin-containing microbubbles for ultrasound-triggered doxorubicin delivery: cytotoxicity and mechanisms involved. - Wikidata - awgldk - TriplyDB

Design and evaluation of doxorubicin-containing microbubbles for ultrasound-triggered doxorubicin delivery: cytotoxicity and mechanisms involved.

Design and evaluation of doxorubicin-containing microbubbles for ultrasound-triggered doxorubicin delivery: cytotoxicity and mechanisms involved.

http://www.wikidata.org/entity/Q30477892

about

Mechanisms of microbubble-facilitated sonoporation for drug and gene delivery.Nanoparticle delivery enhancement with acoustically activated microbubbles.A review of low-intensity ultrasound for cancer therapy.Optimal control of gene mutation in DNA replication Low Intensity Ultrasound Mediated Liposomal Doxorubicin Delivery Using Polymer Microbubbles.Dual-targeted and pH-sensitive Doxorubicin Prodrug-Microbubble Complex with Ultrasound for Tumor Treatment.In vitro methods to study bubble-cell interactions: Fundamentals and therapeutic applications Lipid-Based Drug Delivery Systems in Cancer Therapy: What Is Available and What Is Yet to Come.The influence of blood on targeted microbubbles pH-triggered echogenicity and contents release from liposomes.State-of-the-art materials for ultrasound-triggered drug delivery.Nanobubble ultrasound contrast agents for enhanced delivery of thermal sensitizer to tumors undergoing radiofrequency ablation Flow-focusing regimes for accelerated production of monodisperse drug-loadable microbubbles toward clinical-scale applications Microbubbles coupled to methotrexate-loaded liposomes for ultrasound-mediated delivery of methotrexate across the blood-brain barrier Ultrasound-triggered release of materials entrapped in microbubble-liposome constructs: a tool for targeted drug delivery.Recent advances in molecular, multimodal and theranostic ultrasound imaging.Sonoporation by low-frequency and low-power ultrasound enhances chemotherapeutic efficacy in prostate cancer cells in vitro.A novel cationic microbubble coated with stearic acid-modified polyethylenimine to enhance DNA loading and gene delivery by ultrasound.Phase-shift, stimuli-responsive perfluorocarbon nanodroplets for drug delivery to cancer.Lung surfactant microbubbles increase lipophilic drug payload for ultrasound-targeted delivery.MRI-Guided Focused Ultrasound as a New Method of Drug Delivery.Advances in ultrasound mediated gene therapy using microbubble contrast agents.Leveraging the power of ultrasound for therapeutic design and optimization.Doxorubicin and paclitaxel loaded microbubbles for ultrasound triggered drug delivery.Phase-shift, stimuli-responsive drug carriers for targeted delivery.Applications of magnetic microbubbles for theranostics.Facile One-Pot Synthesis of Polymer-Phospholipid Composite Microbubbles with Enhanced Drug Loading Capacity for Ultrasound-Triggered Therapy Delivery of water-soluble drugs using acoustically triggered perfluorocarbon double emulsions.Gold nanoparticles delivery in mammalian live cells: a critical review Sonoporation enhances chemotherapeutic efficacy in retinoblastoma cells in vitro Development and optimization of a doxorubicin loaded poly(lactic acid) contrast agent for ultrasound directed drug delivery.Magnetic liposomes for colorectal cancer cells therapy by high-frequency magnetic field treatment.Cooperative, heparan sulfate-dependent cellular uptake of dimeric guanidinoglycosides.Pharmacokinetics of quercetin-loaded nanodroplets with ultrasound activation and their use for bioimaging Enzyme-triggered nanomedicine: drug release strategies in cancer therapy.Magnetic targeting and ultrasound mediated drug delivery: benefits, limitations and combination.Oscillating bubbles: a versatile tool for lab on a chip applications.Properties, characteristics and applications of microbubbles for sonothrombolysis.The use of ultrasound to release chemotherapeutic drugs from micelles and liposomes.In Vitro and In Vivo Evaluation of Targeted Sunitinib-Loaded Polymer Microbubbles Against Proliferation of Renal Cell Carcinoma.

P2860

Q26859479-818BB2E6-5773-4742-893B-DCD01763ACBB Q26866082-DAAE1880-E7B7-4483-83C2-7EF33B563F9C Q28082093-B985ECB1-02E3-4216-98B0-F0BE1149215A Q28730945-59B21716-7F3F-432A-98E9-4D5EAB649185 Q30359572-82599664-9591-4102-A75C-E8B09CAB440D Q30362004-3D281D73-3561-428E-AD3B-D4BE1C63B17A Q30364918-6CE5DFA0-2B4F-4DBF-9121-C34D87B5E8C8 Q30366990-0FD8690B-C820-4898-A9AE-5014C5BE9A36 Q30399305-005E14DB-206C-4612-B849-95541B69829B Q30402045-026600C3-493C-4394-ABC8-D586E1B1D534 Q30409234-4116AAAE-80F7-4932-BF9D-4A9E173282FA Q30410530-DCFDA0F3-AFA9-4838-BB99-39062AAF23BB Q30422675-C691DEAE-6660-4F8E-81FA-6C6992D9A2F7 Q30427348-8534FE2D-0481-457E-893D-FD931EE828C4 Q30429680-0C8EEBD1-EBB4-4C62-879F-830CC7355135 Q30436709-C824AB5B-7D29-4B7F-B567-38410E30E804 Q30448283-065F3C93-F744-4562-8231-0478D81876D6 Q30448815-16801EE0-EB41-4620-AF99-DCEBAF44D524 Q30450131-E07F29BA-D76E-4165-B29E-DAF6778C18E6 Q30453426-922CA6F8-ED9C-4ADC-9DDC-EBD589D034C7 Q30453855-F54C88F7-7034-4D46-9E0C-0B54E021216C Q30458491-D62EA077-ECE7-4736-A78B-7F79069F95CD Q30459779-845CAEC9-693D-4C64-9E21-8F4D738D2226 Q30465439-C4811322-0247-4E4D-B197-2F78093EBCEA Q30466278-EDB29BE7-16C5-43A3-A659-BAF2DED0A6C1 Q30471255-E853B332-01DC-4AED-8BD9-9A89C71329F2 Q30471866-33DC3E6B-8773-4E4B-83C7-AE4780031C8C Q30472664-28887AFC-2E0F-41E9-B9F1-9D0DC00967BD Q30472806-D0DC6777-2813-4B76-B2A9-889A3908645C Q30473275-D661F7FA-AD91-4E99-A2FB-9808143D73A9 Q30475985-27B5A941-5EBB-41F9-9002-E5F7FFE2344A Q34213284-653422B0-59F8-4A5C-AF82-235168164EB8 Q34383163-32E30658-0C87-45B6-9B40-B986C61AF0C3 Q35532147-3767B9BB-0B52-4422-8FBB-9FB79915B1E6 Q37799614-BE5DC5F0-10AF-4328-B6FB-16F7BAEA6C4C Q38012538-D3CD3578-05CE-4154-8C52-59F42211435A Q38032126-7AA1437C-20AC-403A-AF99-64D7143E0157 Q38176653-B6EAE133-3EFD-41C1-B348-CC037315A92A Q38247429-A9CE8612-037E-447C-874E-463E8A415D9E Q38790666-935DB1EF-C821-434C-AEFE-BD968A68510B

P2860

Design and evaluation of doxorubicin-containing microbubbles for ultrasound-triggered doxorubicin delivery: cytotoxicity and mechanisms involved.

http://www.wikidata.org/entity/Q30477892

description

2009 nî lūn-bûn

@nan

2009 թուականի Յուլիսին հրատարակուած գիտական յօդուած

@hyw

2009 թվականի հուլիսին հրատարակված գիտական հոդված

@hy

2009年の論文

@ja

2009年論文

@yue

2009年論文

@zh-hant

2009年論文

@zh-hk

2009年論文

@zh-mo

2009年論文

@zh-tw

2009年论文

@wuu

name

Design and evaluation of doxor ...... icity and mechanisms involved.

@ast

Design and evaluation of doxor ...... icity and mechanisms involved.

@en

type

label

Design and evaluation of doxor ...... icity and mechanisms involved.

@ast

Design and evaluation of doxor ...... icity and mechanisms involved.

@en

prefLabel

Design and evaluation of doxor ...... icity and mechanisms involved.

@ast

Design and evaluation of doxor ...... icity and mechanisms involved.

@en

P1433

Q30477892-1E00D8C7-B7EB-4E9C-8A97-BD2F5AC24A25

P1476

Q30477892-DC6A6312-9951-419D-9D41-44A5BB70EE9C

P2093

Q30477892-56BACF29-98C6-4388-B446-A46E4EBDAF78

Q30477892-BF40C568-4B15-4D38-A6EE-9C86EF633C71

Q30477892-F1446957-36A4-4E4F-8850-5ADA59427FF8

P2860

Q30477892-0429D1EA-5A08-478E-B0DE-FF47BA47FDC9

Q30477892-071B47D5-71B3-444E-A367-B83446D8A0A4

Q30477892-0EC02E78-F01F-4F0E-B678-342144A37A3D

Q30477892-0F353620-A46A-48FB-9A05-9224FCEAD3FF

Q30477892-1496A3A8-97E7-43E5-883F-CA613E9BBAA7

Q30477892-1CE57014-8274-4BFD-B567-3DE356B5DE15

Q30477892-2502D76B-47B6-4052-A919-0616ED56C37D

Q30477892-2889AB17-494A-4C4E-9DDC-CD80202BD634

Q30477892-28C2C80C-646C-4552-A98E-EB5DC83F4B5C

Q30477892-3241C95A-CD2A-4524-8EBA-6B02984C2BDE

P304

Q30477892-79ACD786-19AF-4EA8-A546-B7E2BB28817A

P31

Q30477892-D46A66B6-3EA1-471C-973B-3763E73A87A3

P356

Q30477892-4E6B2A50-C256-4291-8FB3-339B049B38B3

P433

Q30477892-ECE08F88-9623-4A2E-8AB1-BB3398B81478

P478

Q30477892-6833C592-AEF7-4FEC-B29C-114B2170263B

P50

Q30477892-14D41441-9DB3-4AD4-AA68-C137A8C92EC1

Q30477892-CB16E923-CEC3-48B0-ACA7-A51FE29CB688

P577

Q30477892-849496DB-CFAE-46E1-92FD-BCC925FD22D7

P5875

Q30477892-FBFCB448-BF96-4121-BB3D-F8FEEA7EE6C0

P698

Q30477892-103C4264-61C7-4652-92AC-CD4E5D2158A4

P921

Q30477892-718BF1C6-9343-434F-B44E-5F227B36032B

P932

Q30477892-E75FA4AF-4B59-4EAF-ABBD-208A189DBF47

P356

P1433

Molecular Therapy

P1476

Design and evaluation of doxor ...... xicity and mechanisms involved

@en

P2093

Bart Geers

http://www.w3.org/2001/XMLSchema#string

Joseph Demeester

http://www.w3.org/2001/XMLSchema#string

Niek N Sanders

http://www.w3.org/2001/XMLSchema#string

P2860

Tumor vascular permeability and the EPR effect in macromolecular therapeutics: a review

Delivery of colloidal particles and red blood cells to tissue through microvessel ruptures created by targeted microbubble destruction with ultrasound.

Driving delivery vehicles with ultrasound.

Drug-loaded nano/microbubbles for combining ultrasonography and targeted chemotherapy.

Micelles and nanoparticles for ultrasonic drug and gene delivery.

Ultrasound mediated delivery of drugs and genes to solid tumors.

The use of ultrasound and micelles in cancer treatment.

Ultrasonic drug delivery--a general review.

Delivery of liposomal doxorubicin (Doxil) in a breast cancer tumor model: investigation of potential enhancement by pulsed-high intensity focused ultrasound exposure.

Fluorescence intensity and lifetime imaging of free and micellar-encapsulated doxorubicin in living cells.

P304

101-108

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1038/MT.2009.160

http://www.w3.org/2001/XMLSchema#string

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

18

http://www.w3.org/2001/XMLSchema#string

P50

Stefaan C De Smedt

P577

2009-07-21T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

26686727

http://www.w3.org/2001/XMLSchema#string

P698

19623162

http://www.w3.org/2001/XMLSchema#string

P921

P932

2839231

http://www.w3.org/2001/XMLSchema#string